Bond Market Signals Inflation Concerns as Kevin Warsh Assumes Fed Leadership UK Households Face Energy Bill Anxiety as Price Cap Forecast to Rise 209 to 1900 Trump Administration Reportedly in Talks to Fund US Drone Manufacturers Implications for Defense Sector Ukraine Gymnastics Federation Seeks Emergency FIG Congress Over Russian Athlete Reinstatement Hitachi Secures Contract for Mexican Railway Signaling System Dow Jones Futures Edge Higher as SP 500 and Nasdaq Reach New Highs AI Stocks Enter Buy Zones BFAM Q1 2026 Earnings EPS Beats Estimates on Operational Strength DAWN Q4 2025 Earnings WiderThanExpected Loss As PreRevenue Biotech Advances Pipeline Limoneira Co LMNR Q1 2026 Earnings EPS Misses Estimates by Over 42 Amid Challenging Winter Season MSEX Q1 2026 Earnings EPS Falls Short of Estimates as Stock Edges Lower Mitek Systems MITK Q1 2026 Earnings EPS Beats Estimates as Stock Gains 436 Team Inc Q1 2026 Earnings Adjusted Loss of 276 Per Share Amid Operational Challenges Jianzhi Education Technology Group JZ Edges Higher Amid Modest Uptick as Shares Hold Above Key Support ENI E Edges Higher Amid Cautious Trading Key Levels in Focus Hilltop Holdings HTH Holds Steady Near Midpoint of Recent Range American Public Education APEI Holds Steady Near 515 as Trading Activity Remains Calm Bitcoin Infrastructure Acquisition Corp BIXI Holds Steady at 997 Consolidation in Focus Clorox CLX Gains Ground Consumer Staples Stock Rebounds Amid Defensive Demand Vuzix Corporation VUZI Surges 9 as Stock Tests Key Resistance at 540 Rhythm Pharmaceuticals RYTM Edges Higher Near Key Resistance After Modest Gain Blue Ridge Bankshares BRBS Edges Higher Approaches Key Resistance at 345 Range Capital Acquisition Corp II Warrants RNGTW Flat at 032 as Warrants Trade Near Support Kymera Therapeutics KYMR Slips Modestly While Holding Above Key Support Astera Labs ALAB Reaches AllTime High Amid Bullish Analyst Rating and Price Target Optimism VNET Q4 2025 Earnings Massive EPS Beat Fails to Lift Stock as Revenue Details Remain Unclear KalVista Pharmaceuticals KALV Holds Steady Near 2679 as Traders Eye Key Support and Resistance Levels